Zobrazeno 1 - 3
of 3
pro vyhledávání: '"556"'
Publikováno v:
Cancer Research. 81:PO-051
Tumor Treating Fields (TTFields) are a non-invasive, loco-regional antimitotic treatment modality, approved for the treatment of glioblastoma and malignant pleural mesothelioma. TTFields at a specific frequency (150-200 kHz) are delivered via arrays
Publikováno v:
Cancer Research. 79:CT176-CT176
Background: Tumor Treating Fields (TTFields) are a non-invasive, regional antimitotic treatment modality, which has been approved for the treatment of patients with glioblastoma by the FDA. TTFields predominantly act by disrupting the formation of th
Autor:
Takeshi Hanagiri, Mitsuhiro Takenoyama, Kenji Sugio, Kosei Yasumoto, Makiko Mizukami, Tetsuya So, Masakazu Sugaya, Fukuyama Takashi, Yoshinobu Ichiki, Tomoko So
Publikováno v:
Cancer research. 66(9)
The purpose of our present study is to identify a tumor-specific antigen capable of inducing a specific cellular immune response in lung cancer patients. We established a lung adenocarcinoma cell line, designated as F1121L, and induced tumor-specific